TomoTherapy names Vaello as VP global sales
Rafael Vaello will join TomoTherapy, producer of the Hi-Art treatment system for advanced radiation therapy, as vice president of global sales, effective Dec. 1.
Vaello, who will report to TomoTherapy CEO Fred Robertson, MD, has spent the previous seven years leading the sales and field marketing group for Philips Healthcare’s Oncology Imaging division.
He brings more than 15 years of sales expertise in the oncology and imaging industries to TomoTherapy, where he will be responsible for enhancing sales performance and expanding the company’s global market presence.
Prior to Philips, Vaello was director, global sales manager, for Marconi Medical Systems’ Oncology division, the company said.
Shawn Guse, who held the role of interim vice president of global sales since August 25, will take on other executive responsibilities within the organization, including continuing as the CEO of TomoTherapy's proton therapy development subsidiary, Compact Particle Acceleration.
Vaello, who will report to TomoTherapy CEO Fred Robertson, MD, has spent the previous seven years leading the sales and field marketing group for Philips Healthcare’s Oncology Imaging division.
He brings more than 15 years of sales expertise in the oncology and imaging industries to TomoTherapy, where he will be responsible for enhancing sales performance and expanding the company’s global market presence.
Prior to Philips, Vaello was director, global sales manager, for Marconi Medical Systems’ Oncology division, the company said.
Shawn Guse, who held the role of interim vice president of global sales since August 25, will take on other executive responsibilities within the organization, including continuing as the CEO of TomoTherapy's proton therapy development subsidiary, Compact Particle Acceleration.